In 2013 New Scientist reported that "tests on rats showed that at all doses, the drug rapidly causes cancers in a multitude of organs, including the liver, bladder, stomach, skin, thyroid, tongue, testes, ovaries and womb."[4] In 2013 WADA took the rare step of warning potential users of the compound of the possible health risks. They stated "clinical approval has not, and will not be given for this substance".[2][24]
-- have fun getting cancer.. gw501516 has shown in several studies it directly causes it.
Weren't you just recommending gw50 to that 19yr old kid in another thread lol?
yah, didn't come across all the studies directly linking it to cancer until after I had already posted to him.
Why link to random info when I've made an info thread right here on ology?:
http://www.steroidology.com/forum/a...sarms-info-thread-hosted-sarmssearch-com.html
GW was said to cause cancer in rats when given extreme doses. Think about that. Rats. Extreme doses. When compared to a human, it came out to be in the 100s of mgs as daily dosages, and we only recommend taking 20mg TOPS per day...
GW is wonderful. Promotes cardio endurance, muscular endurance so you last longer with weights, and it's also known to burn fat. Perfection in my opinion
Actually, if you read the studies, a variety of cancers (in about 10 organ systems) were promoted AT ALL DOSES STUDIED, not just the high doses. The lowest dose studied translates to around 300-400mg per day in an avg sized male, but they stopped all research before finding the lower threshold. So no one really knows at what dose the cancer starts. In the only studies we have to look at, ALL DOSES CAUSED CANCER, and no studies were performed which looked at the equivalent to 20mg per day in humans.
I can't see any basis to believe that 20mg is safe. Perhaps you have access to more data?
Also, isn't it just a little bit self-serving to post rat studies to prove the drug burns fat and aids endurance, then turn around say "don't trust safety studies done on rats because they're rats and different than humans." ???
How are you going to know what's working when on all those compounds?Yeah Bro currently running test, tren, clen and t3. So I'm curious to see another compound with a fat burning effect. It's supposed to help tremendously with the shortness of breath caused by the tren as well
How are you going to know what's working when on all those compounds?
Are you a rep for SarmSearch?
Well dudes yesterday's workout once again was pretty intense. I can definitely see the difference in my muscular and cardiovascular endurance. The real test will be leg day when I hit squats. Which might be today or tomorrow. I'm not really sure yet. It's my birthday and I don't know if I'll be hitting the gym yet.
Well dudes yesterday's workout once again was pretty intense. I can definitely see the difference in my muscular and cardiovascular endurance. The real test will be leg day when I hit squats. Which might be today or tomorrow. I'm not really sure yet. It's my birthday and I don't know if I'll be hitting the gym yet.
Until one of us run our own studies we will never know, and even then we will have conflicting info...same as some believing French fries give you cancer. We live in a hypochondriac society.
From the studies IVE read, here is what I gather. The doses they gave were ridiculously high. I'm talking like 5mg/kg bodyweight was the LOWEST. Do the math, that's a lot even for a small child.
I am sure quite a few things will give you cancer at 80+ times their normal dose.
If I'm not mistaken the size and frequency of cancer was also correlated with dosage, so assuming the correlation is linear at 5mg in a 50-100kg man, your risk is minimal. Also, based on the theory behind the ppar-Delta mechanism it seems that a COX2 inhibitor should prevent or at least reduce risk of cancer.
yah, didn't come across all the studies directly linking it to cancer until after I had already posted to him.
":""""""""""""""
{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid
GW501516 (GW1516 or GSK-516) is a drug that acts as a PPARd modulator. GW 501516 activates AMP-activated protein kinase and stimulates glucose uptake in skeletal muscle tissue, and GW 501516 has been demonstrated to reverse metabolic abnormalities in obese men with pre-diabetic metabolic syndrome, most likely by stimulating fatty acid oxidation. It has been proposed as a potential treatment for obesity and related conditions, especially when used in conjunction with a synergistic compound AICAR, as the combination has been shown to significantly increase exercise endurance in animal studies.
GW-50156 regulates fat burning through a number of widespread mechanisms; it increases glucose uptake in skeletal muscle tissue and increases muscle gene expression, especially genes involved in preferential lipid utilization. This shift changes the body***8217;s metabolism to favor burning fat for energy instead of carbohydrates or muscle protein, potentially allowing clinical application for obese patients to lose fat effectively without experiencing muscle catabolism or the effects and satiety issues associated with low blood sugar. GW-501516 also increases muscle mass, which improved glucose tolerance and reduced fat mass accumulation even in mice fed a very high fat diet, suggesting that GW-501516 may have a protective effect against obesity.
GW501516 is a selective agonist (activator) of the PPAR***948; receptor. It displays high affinity (Ki = 1 nM) and potency (EC50 = 1 nM) for PPAR***948; with > 1000 fold selectivity over PPAR***945; and PPAR***947;.
In rats, binding of GW501516 to PPAR***948; recruits the co activator PGC-1a. The PPAR***948;/coactivator complex in turn up regulates the expression of proteins involved in energy expenditure. Furthermore in rats treated with GW501516, increased fatty acid metabolism in skeletal muscle and protection against diet-induced obesity and type II diabetes was observed. In obese rhesus monkeys, GW501516 increased high-density lipoprotein (HDL) and lowered very-low-density lipoprotein (VLDL). The mechanism by which PPAR***948; agonists increase HDL appears to be a result of increased expression of the cholesterol transporter ABCA1.
This article is intended for educational / informational purposes only. THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
- See more at: http://www.sarms1.com/gw-501516#sthash.p48U7pKt.dpuf"""""""""""""
this is from the sarms1 website. basically increases your cardiovascular levels, increases endurance, and drops body fat, also anti-catabolic
Actually, if you read the studies, a variety of cancers (in about 10 organ systems) were promoted AT ALL DOSES STUDIED, not just the high doses. The lowest dose studied translates to around 300-400mg per day in an avg sized male, but they stopped all research before finding the lower threshold. So no one really knows at what dose the cancer starts. In the only studies we have to look at, ALL DOSES CAUSED CANCER, and no studies were performed which looked at the equivalent to 20mg per day in humans.
I can't see any basis to believe that 20mg is safe. Perhaps you have access to more data?
Also, isn't it just a little bit self-serving to post rat studies to prove the drug burns fat and aids endurance, then turn around say "don't trust safety studies done on rats because they're rats and different than humans." ???
^^this.. somebody who doesn't follow the status quo on this website and thinks logically outside of the ology regime lol.
Until one of us run our own studies we will never know, and even then we will have conflicting info...same as some believing French fries give you cancer. We live in a hypochondriac society.
From the studies IVE read, here is what I gather. The doses they gave were ridiculously high. I'm talking like 5mg/kg bodyweight was the LOWEST. Do the math, that's a lot even for a small child.
I am sure quite a few things will give you cancer at 80+ times their normal dose.
If I'm not mistaken the size and frequency of cancer was also correlated with dosage, so assuming the correlation is linear at 5mg in a 50-100kg man, your risk is minimal. Also, based on the theory behind the ppar-Delta mechanism it seems that a COX2 inhibitor should prevent or at least reduce risk of cancer.
I have not seen any data on "size," can you share this?If I'm not mistaken the size and frequency of cancer was also correlated with dosage, so assuming the correlation is linear at 5mg in a 50-100kg man, your risk is minimal.
Also, based on the theory behind the ppar-Delta mechanism it seems that a COX2 inhibitor should prevent or at least reduce risk of cancer.